Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis.

Keravec M, Mounier J, Guilloux CA, Fangous MS, Mondot S, Vallet S, Gouriou S, Le Berre R, Rault G, Férec C, Barbier G, Lepage P, Héry-Arnaud G.

BMJ Open Respir Res. 2019 Mar 12;6(1):e000374. doi: 10.1136/bmjresp-2018-000374. eCollection 2019.

2.

Using registry data to improve quality of care.

McIntyre K, Bertrand DP, Rault G.

J Cyst Fibros. 2018 Sep;17(5):566-572. doi: 10.1016/j.jcf.2018.06.006. Epub 2018 Jul 5. Review.

PMID:
30196852
3.

Introduction of a collaborative quality improvement program in the French cystic fibrosis network: the PHARE-M initiative.

Pougheon Bertrand D, Minguet G, Lombrail P, Rault G.

Orphanet J Rare Dis. 2018 Feb 8;13(Suppl 1):12. doi: 10.1186/s13023-017-0745-7.

4.

Lessons from the on-site quality audit of data transmitted to the French cystic fibrosis registry.

Pellen N, Guéganton L, Pougheon Bertrand D, Rault G.

Orphanet J Rare Dis. 2018 Feb 8;13(Suppl 1):9. doi: 10.1186/s13023-017-0750-x.

5.

Quality of care in cystic fibrosis: assessment protocol of the French QIP PHARE-M.

Pougheon Bertrand D, Nowak E, Dehillotte C, Lemmonier L, Rault G.

Orphanet J Rare Dis. 2018 Feb 8;13(Suppl 1):10. doi: 10.1186/s13023-017-0749-3.

6.

Strategies for care quality improvement in Cystic Fibrosis.

Rault G, Lombrail P.

Orphanet J Rare Dis. 2018 Feb 8;13(Suppl 1):26. doi: 10.1186/s13023-017-0743-9. No abstract available.

7.

Pneumocystis jirovecii and Cystic Fibrosis in Brittany, France.

Nevez G, Robert-Gangneux F, Pougnet L, Virmaux M, Belleguic C, Deneuville E, Rault G, Chevrier S, Ramel S, Le Bihan J, Guillaud-Saumur T, Calderon E, Le Govic Y, Gangneux JP, Le Gal S.

Mycopathologia. 2018 Feb;183(1):81-87. doi: 10.1007/s11046-017-0172-2. Epub 2017 Jul 7.

PMID:
28688008
8.

Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease.

Hubert D, Chiron R, Camara B, Grenet D, Prévotat A, Bassinet L, Dominique S, Rault G, Macey J, Honoré I, Kanaan R, Leroy S, Desmazes Dufeu N, Burgel PR.

J Cyst Fibros. 2017 May;16(3):388-391. doi: 10.1016/j.jcf.2017.03.003. Epub 2017 Mar 18.

9.

Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study.

Héry-Arnaud G, Nowak E, Caillon J, David V, Dirou A, Revert K, Munck MR, Frachon I, Haloun A, Horeau-Langlard D, Le Bihan J, Danner-Boucher I, Ramel S, Pelletier MP, Rosec S, Gouriou S, Poulhazan E, Payan C, Férec C, Rault G, Le Gal G, Le Berre R.

Clin Microbiol Infect. 2017 Mar;23(3):203-207. doi: 10.1016/j.cmi.2016.11.016. Epub 2016 Nov 27.

10.

Highlighting the impact of cascade carrier testing in cystic fibrosis families.

Duguépéroux I, L'Hostis C, Audrézet MP, Rault G, Frachon I, Bernard R, Parent P, Blayau M, Schmitt S, Génin E, Férec C, Scotet V.

J Cyst Fibros. 2016 Jul;15(4):452-9. doi: 10.1016/j.jcf.2016.02.013. Epub 2016 Mar 22.

11.

Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Meijer L, Nelson DJ, Riazanski V, Gabdoulkhakova AG, Hery-Arnaud G, Le Berre R, Loaëc N, Oumata N, Galons H, Nowak E, Gueganton L, Dorothée G, Prochazkova M, Hall B, Kulkarni AB, Gray RD, Rossi AG, Witko-Sarsat V, Norez C, Becq F, Ravel D, Mottier D, Rault G.

J Innate Immun. 2016;8(4):330-49. doi: 10.1159/000444256. Epub 2016 Mar 18. Review.

12.

[Analysis of hospital outpatient care of a rare disease: cystic fibrosis].

Rault G, Pougheon D, Moisdon JC, Pépin M, Kletz F, Bellon G, Durieu I, Lombrail P.

Sante Publique. 2015 May-Jun;27(3):363-72. French.

PMID:
26414138
13.

Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization.

Keravec M, Mounier J, Prestat E, Vallet S, Jansson JK, Burgaud G, Rosec S, Gouriou S, Rault G, Coton E, Barbier G, Héry-Arnaud G.

Springerplus. 2015 Aug 9;4:405. doi: 10.1186/s40064-015-1207-0. eCollection 2015.

14.

Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.

Rivas Caldas R, Le Gall F, Revert K, Rault G, Virmaux M, Gouriou S, Héry-Arnaud G, Barbier G, Boisramé S.

J Clin Microbiol. 2015 Jun;53(6):1898-907. doi: 10.1128/JCM.00368-15. Epub 2015 Apr 8.

15.

Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation.

Bernarde C, Keravec M, Mounier J, Gouriou S, Rault G, Férec C, Barbier G, Héry-Arnaud G.

PLoS One. 2015 Apr 8;10(4):e0124124. doi: 10.1371/journal.pone.0124124. eCollection 2015.

16.

Costs and health-related quality of life of patients with cystic fibrosis and their carers in France.

Chevreul K, Berg Brigham K, Michel M, Rault G; BURQOL-RD Research Network.

J Cyst Fibros. 2015 May;14(3):384-91. doi: 10.1016/j.jcf.2014.11.006. Epub 2015 Jan 22.

17.

European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis.

Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, Pressler T, Rault G, Viviani L, Elborn JS, Castellani C.

J Cyst Fibros. 2014 May;13 Suppl 1:S43-59. doi: 10.1016/j.jcf.2014.03.011. Review.

18.

[National French guidelines for management of infants with cystic fibrosis].

Sermet-Gaudelus I, Couderc L, Vrielynck S, Brouard J, Weiss L, Wizla N, Llerena C, Lebourgeois M, Bailly C, Dirou A, Renouil M, Dalphin ML, Rault G, Munck A, Roussey M; Groupe de travail dépistage de la Fédération des centres de ressources et de compétences de la mucoviscidose; Groupe de travail dépistage de la Fédération des centres de ressources et de compétences de la mucoviscidose.

Arch Pediatr. 2014 Jun;21(6):654-62. doi: 10.1016/j.arcped.2014.03.014. Epub 2014 May 10. French.

PMID:
24815598
19.

Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients.

Mounier J, Gouëllo A, Keravec M, Le Gal S, Pacini G, Debaets S, Nevez G, Rault G, Barbier G, Héry-Arnaud G.

J Microbiol. 2014 Apr;52(4):307-14. doi: 10.1007/s12275-014-3425-5. Epub 2014 Feb 17.

PMID:
24535743
20.

Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis.

Le Gall F, Le Berre R, Rosec S, Hardy J, Gouriou S, Boisramé-Gastrin S, Vallet S, Rault G, Payan C, Héry-Arnaud G.

BMC Microbiol. 2013 Jun 21;13:143. doi: 10.1186/1471-2180-13-143.

21.

CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.

Thauvin-Robinet C, Munck A, Huet F, de Becdelièvre A, Jimenez C, Lalau G, Gautier E, Rollet J, Flori J, Nové-Josserand R, Soufir JC, Haloun A, Hubert D, Houssin E, Bellis G, Rault G, David A, Janny L, Chiron R, Rives N, Hairion D, Collignon P, Valeri A, Karsenty G, Rossi A, Audrézet MP, Férec C, Leclerc J, Georges Md, Claustres M, Bienvenu T, Gérard B, Boisseau P, Cabet-Bey F, Cheillan D, Feldmann D, Clavel C, Bieth E, Iron A, Simon-Bouy B, Izard V, Steffann J, Viville S, Costa C, Drouineaud V, Fauque P, Binquet C, Bonithon-Kopp C, Morris MA, Faivre L, Goossens M, Roussey M, Girodon E; collaborating working group on p.Arg117His.

J Med Genet. 2013 Apr;50(4):220-7. doi: 10.1136/jmedgenet-2012-101427. Epub 2013 Feb 1.

PMID:
23378603
22.

CFTR biomarkers: time for promotion to surrogate end-point.

De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe SM, Middleton P, de Jonge H, Bronsveld I, Wilschanski M, Melotti P, Danner-Boucher I, Boerner S, Fajac I, Southern K, de Nooijer RA, Bot A, de Rijke Y, de Wachter E, Leal T, Vermeulen F, Hug MJ, Rault G, Nguyen-Khoa T, Barreto C, Proesmans M, Sermet-Gaudelus I; European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee.

Eur Respir J. 2013 Jan;41(1):203-16. doi: 10.1183/09031936.00057512. Epub 2012 Aug 9. Review.

23.

Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France.

Scotet V, Duguépéroux I, Saliou P, Rault G, Roussey M, Audrézet MP, Férec C.

Orphanet J Rare Dis. 2012 Mar 1;7:14. doi: 10.1186/1750-1172-7-14.

24.

Frequency of aquagenic palmoplantar keratoderma in cystic fibrosis: a new sign of cystic fibrosis?

Garçon-Michel N, Roguedas-Contios AM, Rault G, Le Bihan J, Ramel S, Revert K, Dirou A, Misery L.

Br J Dermatol. 2010 Jul;163(1):162-6. doi: 10.1111/j.1365-2133.2010.09764.x. Epub 2010 Mar 10.

PMID:
20302572
25.

Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up.

Beucher J, Leray E, Deneuville E, Roblin M, Pin I, Bremont F, Turck D, Giniès JL, Foucaud P, Rault G, Derelle J, David V, Journel H, Marchand S, Veillard D, Roussey M.

J Pediatr. 2010 May;156(5):771-6, 776.e1. doi: 10.1016/j.jpeds.2009.12.003. Epub 2010 Feb 20.

PMID:
20171652
26.

Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening.

Walsh AC, Rault G, Li Z, Scotet V, Duguépéroux I, Férec C, Roussey M, Laxova A, Farrell PM; participating CF centres of Brittany, France.

J Cyst Fibros. 2010 Jan;9(1):44-50. doi: 10.1016/j.jcf.2009.10.004. Epub 2009 Nov 18.

27.

The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.

Thauvin-Robinet C, Munck A, Huet F, Génin E, Bellis G, Gautier E, Audrézet MP, Férec C, Lalau G, Georges MD, Claustres M, Bienvenu T, Gérard B, Boisseau P, Cabet-Bey F, Feldmann D, Clavel C, Bieth E, Iron A, Simon-Bouy B, Costa C, Medina R, Leclerc J, Hubert D, Nové-Josserand R, Sermet-Gaudelus I, Rault G, Flori J, Leroy S, Wizla N, Bellon G, Haloun A, Perez-Martin S, d'Acremont G, Corvol H, Clément A, Houssin E, Binquet C, Bonithon-Kopp C, Alberti-Boulmé C, Morris MA, Faivre L, Goossens M, Roussey M; Collaborating Working Group on R117H, Girodon E.

J Med Genet. 2009 Nov;46(11):752-8. doi: 10.1136/jmg.2009.067215. Epub 2009 Jun 29.

PMID:
19880712
28.

Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations.

Roussey M, Le Bihannic A, Scotet V, Audrezet MP, Blayau M, Dagorne M, David V, Deneuville E, Giniès JL, Laurans M, Moisan-Petit V, Rault G, Vigneron P, Férec C.

J Inherit Metab Dis. 2007 Aug;30(4):613. Epub 2007 Jul 12.

PMID:
17632692
29.
30.

Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?

Scotet V, Audrézet MP, Roussey M, Rault G, Dirou-Prigent A, Journel H, Moisan-Petit V, Storni V, Férec C.

Pediatrics. 2006 Nov;118(5):e1523-9. Epub 2006 Oct 2.

PMID:
17015492
31.

Cystic fibrosis mortality trends in France.

Bellis G, Cazes MH, Parant A, Gaimard M, Travers C, Le Roux E, Ravilly S, Rault G.

J Cyst Fibros. 2007 May;6(3):179-86. Epub 2006 Aug 17.

32.

[Neonatal screening of cystic fibrosis: diagnostic and ethical problems with mild mutations].

Roussey M, Le Bihannic A, Audrezet MP, Blayau M, Dagorne M, Deneuville E, Férec C, Journel H, Moisan-Petit V, Rault G, Scotet V, Storni V, Vigneron P.

Arch Pediatr. 2005 Jun;12(6):650-3. French. No abstract available.

PMID:
15904758
33.

Reproductive attitudes of couples having a child with cystic fibrosis in Brittany (France).

De Braekeleer M, Rault G, Bellis G.

J Hum Genet. 2004;49(6):285-9. Epub 2004 Apr 23.

PMID:
15105997
34.

Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France.

Scotet V, Audrézet MP, Roussey M, Rault G, Blayau M, De Braekeleer M, Férec C.

Hum Genet. 2003 Aug;113(3):280-5. Epub 2003 May 27.

PMID:
12768409
35.

Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).

Siret D, Bretaudeau G, Branger B, Dabadie A, Dagorne M, David V, de Braekeleer M, Moisan-Petit V, Picherot G, Rault G, Storni V, Roussey M.

Pediatr Pulmonol. 2003 May;35(5):342-9.

PMID:
12687590
36.

Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960.

Scotet V, Gillet D, Duguépéroux I, Audrézet MP, Bellis G, Garnier B, Roussey M, Rault G, Parent P, De Braekeleer M, Férec C; Réseau Mucoviscidose Bretagne et Pays de Loire.

Hum Genet. 2002 Sep;111(3):247-54. Epub 2002 Aug 1.

PMID:
12215837
37.

Stress in conic piles determined by a centrifuge experiment: breakdown of scaling hypothesis.

Evesque P, Noblet S, Rault G.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1999 Jun;59(6):R6259-62.

PMID:
11969733
38.

[Mucoviscidosis: recommendations for organization of centers and patient care systems].

Rault G, Roussey M, Desrues B, Turck D, Perez T, Wallaert B, Derelle J, Tréguer R.

Arch Pediatr. 2001 Dec;8 Suppl 5:802s-817s. French. No abstract available.

PMID:
11811050
39.

Disease knowledge in a high-risk population for cystic fibrosis.

Braekeleer MD, Bellis G, Rault G, Allard C, Milot M, Simard F.

Patient Educ Couns. 2001 Jun;43(3):263-8.

PMID:
11384824
40.

[Does neonatal screening of cystic fibrosis affect outcome? Comparative study of two cohorts in Britanny and Loire-Atlantique with follow-up after ten years].

Siret D, Branger B, Storni V, Bretaudeau G, Dagorne M, Moisan-Petit V, David V, Picherot G, Rault G, Roussey M.

Arch Pediatr. 2000 Nov;7(11):1154-62. French.

PMID:
11109941
41.

Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.

Vassal S, Taamma R, Marty N, Sardet A, d'athis P, Brémont F, Dalphin ML, Plésiat P, Rault G, Thubert J, Dominique S, Lemeland JF, Derelle J, Blech MF, Roussey M, Perrin M, Sautegeau A.

Am J Infect Control. 2000 Oct;28(5):347-51.

PMID:
11029133
42.

Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis.

Scotet V, de Braekeleer M, Roussey M, Rault G, Parent P, Dagorne M, Journel H, Lemoigne A, Codet JP, Catheline M, David V, Chaventré A, Duguépéroux I, Verlingue C, Quéré I, Mercier B, Audrézet MP, Férec C.

Lancet. 2000 Sep 2;356(9232):789-94.

PMID:
11022925
43.

Reproductive attitudes of couples having a child with cystic fibrosis in Saguenay-Lac-Saint-Jean (Quebec, Canada).

De Braekeleer M, Bellis G, Rault G, Allard C, Milot M, Simard F.

Ann Genet. 2000 Apr-Jun;43(2):93-7.

PMID:
10998451
44.

Cystic fibrosis mutations: report from the French Registry. The Clinical Centers of the CF.

Guilloud-Bataille M, De Crozes D, Rault G, Degioanni A, Feingold J.

Hum Hered. 2000 Mar-Apr;50(2):142-5.

PMID:
10799974
45.

Complex allele [-102T>A+S549R(T>G)] is associated with milder forms of cystic fibrosis than allele S549R(T>G) alone.

Romey MC, Guittard C, Chazalette JP, Frossard P, Dawson KP, Patton MA, Casals T, Bazarbachi T, Girodon E, Rault G, Bozon D, Seguret F, Demaille J, Claustres M.

Hum Genet. 1999 Jul-Aug;105(1-2):145-50.

PMID:
10480369
46.

[Clinical networks and cystic fibrosis].

Foucaud P, Rault G, Sautegeau A, Navarro J.

Arch Pediatr. 1996;3 Suppl 1:312s-314s. French. No abstract available.

PMID:
8796052
47.

[Cystic fibrosis: current treatment and perspectives].

Rault G.

Soins Pediatr Pueric. 1995 Nov-Dec;(167-168):12-20. French. No abstract available.

PMID:
8715095
48.

[Cystic fibrosis. Epidemiology, physiopathology and symptoms].

Rault G.

Soins Pediatr Pueric. 1995 Nov-Dec;(167-168):5-11. French. No abstract available.

PMID:
8715094
49.

Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses.

Férec C, Verlingue C, Parent P, Morin JF, Codet JP, Rault G, Dagorne M, Lemoigne A, Journel H, Roussey M, et al.

Hum Genet. 1995 Nov;96(5):542-8.

PMID:
8530001
50.

Eating and emotional disorders in adolescent obese girls with insulin-dependent diabetes mellitus.

Vila G, Robert JJ, Nollet-Clemencon C, Vera L, Crosnier H, Rault G, Jos J, Mouren-Simeoni MC.

Eur Child Adolesc Psychiatry. 1995 Oct;4(4):270-9.

PMID:
8608392

Supplemental Content

Support Center